The predicted target genes of the LINC00114/miR-216a-5p axis include uromodulin Like 1 (UMODL1) and oncoprotein induced transcript 3 (OIT3), which are closely related to the survival and prognosis of COAD patients. In summary, we constructed a novel ceRNA regulatory network and identified potential biomarkers for the targeted therapy and prognosis of COAD.
Our study first showed that several eccDNAs were aberrantly expressed in LAD, among which CircD-PDZRN3 and CircD-LGR6 clearly distinguished LAD patients from healthy controls, indicating their potential as biomarkers.
over 3 years ago
Journal
|
CEACAM5 (CEA Cell Adhesion Molecule 5) • KRT19 (Keratin 19) • SDK1 (Sidekick Cell Adhesion Molecule 1) • SLC16A3 (Solute Carrier Family 16 Member 3) • UMODL1 (Uromodulin Like 1)
The combination of toripalimab plus paclitaxel and carboplatin is safe, feasible, and effective in locally advanced resectable ESCC, indicating its potential as a neoadjuvant treatment for ESCC.